GGT1 and cancer: We have already reported that gGlu-HMRG, a gamma-glutamyl transpeptidase (GGT)- activatable fluorescence probe, is available to detect ovary18, breast21 and lung22 cancers, and a dipeptidyl peptidase IV- activatable fluorescence probe could detect esophageal cancer19.